SLC-1 Activators
SLC-1 Activators are a spectrum of chemical compounds that enhance the functional activity of SLC-1 through an array of signaling pathways and ionic modulation mechanisms. Cyclosporin A, through its inhibition of calcineurin, might prevent the dephosphorylation of SLC-1-associated proteins, thus maintaining SLC-1 in an active state. Similarly, Verapamil's role in altering cellular calcium homeostasis can lead to an upregulation of SLC-1 function. The activity of SLC-1 is further potentiated by PMA, which activates PKC, leading to the phosphorylation of proteins that aid in SLC-1's trafficking to the cellular membrane. Modulation of intracellular pH and sodium concentrations by Monensin can enhance the activity of sodium-dependent SLC-1 transporters, while Amiloride's sparing of intracellular potassium heightens the activity of SLC-1 transporters by conserving the sodium gradient.
The biochemical landscape in which SLC-1 operates is further influenced by Forskolin, which by elevating cAMP levels and activating PKSLC-1 Activators are a spectrum of chemical compounds that enhance the functional activity of SLC-1 through an array of signaling pathways and ionic modulation mechanisms. Cyclosporin A, through its inhibition of calcineurin, might prevent the dephosphorylation of SLC-1-associated proteins, thus maintaining SLC-1 in an active state. Similarly, Verapamil's role in altering cellular calcium homeostasis can lead to an upregulation of SLC-1 function. The activity of SLC-1 is further potentiated by PMA, which activates PKC, leading to the phosphorylation of proteins that aid in SLC-1's trafficking to the cellular membrane. Modulation of intracellular pH and sodium concentrations by Monensin can enhance the activity of sodium-dependent SLC-1 transporters, while Amiloride's sparing of intracellular potassium heightens the activity of SLC-1 transporters by conserving the sodium gradient.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that binds to cyclophilins and inhibits calcineurin. By inhibiting calcineurin, Cyclosporin A can enhance the activity of SLC-1 by preventing the dephosphorylation of proteins involved in the trafficking and function of SLC-1 transporters. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
A calcium channel blocker that can increase the functional activity of SLC-1 by altering cellular calcium homeostasis, which is known to affect the trafficking and activity of various SLC transporters. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
A PKC activator that can enhance the activity of SLC-1 by phosphorylation of proteins that modulate SLC-1 trafficking and membrane insertion. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
A carboxylic ionophore that alters intracellular pH and sodium concentrations. By affecting these ionic gradients, Monensin can enhance the activity of sodium-dependent SLC-1 transporters. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
A potassium-sparing diuretic that can indirectly enhance SLC-1 activity, particularly if SLC-1 is a sodium-dependent exchanger, by preventing the loss of intracellular sodium. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
An adenylate cyclase activator that raises cAMP levels and activates PKA. PKA can then phosphorylate and enhance the activity of SLC-1 by increasing its trafficking to the plasma membrane. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
A chloride channel blocker that could enhance the activity of SLC-1 by modulating the chloride homeostasis in cells, which in turn can affect the function of chloride-dependent SLC transporters. | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
A sodium channel blocker that, by modifying the sodium gradient, could indirectly enhance the activity of sodium-dependent SLC-1 transporters. | ||||||
Valinomycin | 2001-95-8 | sc-200991 | 25 mg | $250.00 | 3 | |
A potassium ionophore that could enhance the activity of potassium-sensitive SLC-1 transporters by altering the intracellular and extracellular potassium gradient. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
A calmodulin antagonist that can indirectly enhance SLC-1 activity by inhibiting calmodulin-dependent processes that may regulate SLC-1 function. | ||||||